Status:
COMPLETED
Electro-acupuncture at Zusanli, Qihai, and Guanyuan Acupoints Regulate Immune Function in Patients With Sepsis
Lead Sponsor:
Guangdong Provincial Hospital of Traditional Chinese Medicine
Conditions:
Sepsis
Immune Dysfunction
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The purpose of this study was to investigate the biochemical and clinical effects of electro-acupuncture in patients with sepsis.
Detailed Description
Patients were randomly divided into an electro-acupuncture (EA) group and a Western medicine group(WM group) using restricted block randomization (1:1 ratio). Patients in the Western medicine group r...
Eligibility Criteria
Inclusion
- Diagnosis of sepsis;
- Signed the informed consent form.
Exclusion
- Pregnancy or psychiatric disorder;
- Immune deficiency or using immunosuppressants or immune enhancers;
- History of malignancy;
- HIV positive;
- Unwilling to participate in the study or cooperate with the treatment. Patients who cannot tolerate electroacupuncture treatment or loss of follow-up for complicating with other diseases during the study would be dropped off.
Key Trial Info
Start Date :
July 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2022
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT05367986
Start Date
July 1 2019
End Date
January 30 2022
Last Update
May 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
2nd Affiliated Hospital of Guangzhou University of Chinese Medicine
Guangzhou, Guangdong, China, 510000